Matinas Biopharma Hl (MTNB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2021 | 03-2021 | 12-2020 | 09-2020 | 06-2020 | |
| Sales | 0 | 33 | 63 | 96 | 0 |
| Gross Profit | N/A | 33 | 63 | 96 | N/A |
| Operating Expenses | 4,790 | 6,386 | 6,551 | 5,700 | 5,767 |
| Operating Income | -4,790 | -6,353 | -6,489 | -5,605 | -5,767 |
| Other Income | -1 | 1,397 | 148 | 155 | 156 |
| Pre-tax Income | -4,791 | -4,956 | -6,341 | -5,450 | -5,611 |
| Net Income Continuous | -4,791 | -4,956 | -6,341 | -5,450 | -5,611 |
| Net Income | $-4,791 | $-4,956 | $-6,341 | $-5,450 | $-5,611 |
| EPS Basic Total Ops | -1.00 | -1.50 | -1.50 | -1.50 | -1.50 |
| EPS Basic Continuous Ops | -1.17 | -1.22 | -1.59 | -1.37 | -1.42 |
| EPS Diluted Total Ops | -1.00 | -1.50 | -1.50 | -1.50 | -1.50 |
| EPS Diluted Continuous Ops | -1.17 | -1.22 | -1.59 | -1.37 | -1.42 |
| EBITDA(a) | $-4,553 | $-6,101 | $-6,058 | $-5,416 | $-5,570 |